To Dodge Mensing, Plaintiffs May Target Foreign Drugmakers

Law360, New York (October 29, 2013, 8:40 PM EDT) -- Though an Arkansas federal court dismissed drug defect claims against an Indian manufacturer on Monday, attorneys believe more and more plaintiffs injured by generic drugs could go after foreign contract manufacturers in their desperate attempt to find defendants unprotected by the U.S. Supreme Court's Mensing and Bartlett decisions.

U.S. District Judge J. Leon Holmes ruled that his court lacked jurisdiction over Claris Lifesciences Ltd. and its subsidiary Claris Lifesciences Inc. in two lawsuits brought by Arkansas residents claiming the antibiotic metronidazole that they had ingested was...
To view the full article, register now.